Comparison of detection methods and follow-up study on the tyrosine kinase inhibitors therapy in non-small cell lung cancer patients with ROS1 fusion rearrangementJieyu Wu(Nanjing University of Chinese Medicine), Xia Gu(First Affiliated Hospital of Guangzhou Medical University)BMC CancerAugust 3, 201610.1186/s12885-016-2582-9Cited by 26SaveCiteExport RISWatch citationsRelated PapersDisruption of the Clock Component Bmal1 in Mice Promotes Cancer Metastasis through the PAI‐1‐TGF‐<i>β</i>‐myoCAF‐Dependent Mechanism|Advanced Science|2023|38